Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism

NCT01576146 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated early to allow subjects to roll over to study NCT02102204.

Conditions

Interventions

Sponsor

KAI Pharmaceuticals